NLRP3 gene expression levels could be used as a biomarker to improve diagnosis and prognosis in skeletal muscle from animal models and also to support diagnosis in clinical practice with the blood of ALS patients. The gene discussed is NLRP3; the disease is amyotrophic lateral sclerosis.